The recent outburst of GLP-1 drugs triggered an unprecedented patent battle in the pharmaceutical industry as generic manufacturers are trying to

On December 7, 2023, the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) issued a notice-and-comment period for their new

During recent years, the Western District of Texas has been the busiest federal court for patent lawsuits in the US.[i] However, before July

When the framers of the Constitution granted Congress the power “[t]o promote the Progress of Science and useful Arts, by securing for limited Times to

The COVID-19 pandemic raised the question of whether the U.S. patent system should accomplish more than purely incentivize innovation. As Prof. Mariam Marcowitz-Bitton suggests, there

The Bayh-Dole Act of 1980 allows small businesses and non-profit organizations such as universities to retain ownership of inventions made with federal funding and profit

Normally, the plaintiff in a patent infringement case gets to choose where to file their lawsuit. However, when a plaintiff sues a customer for using

On July 20, 2018, the Federal Circuit held in Saint Regis Mohawk Tribe v. Mylan Pharmaceuticals, Inc. that Native American tribes cannot assert tribal

A few weeks ago, on February 19^th, 2019, the Supreme Court heard oral arguments in Return Mail, Inc. v. United States Postal Service. 868 F.3d 1350 (Fed.

On March 5^th, 2019, the Supreme Court granted writ of certiorari in Iancu v. NantKwest Inc. The question for the Court is whether the phrase “[a]ll the